Faropoint, which was launched in Tel Aviv 10 years ago, is expanding into new markets in the U.S. and accessing new types of investors with its focus on smaller last-mile facilities in growing urban markets.
Several recent conduits offer a glimmer of hope that the market will find its footing again.
Buyers are beginning to ask for discounts and some deals fall through. But experts say the disturbance in the sector is based on “short-term uncertainty.”
Which U.S. life sciences markets are seeing the most tenant demand? A new CBRE report takes a close look at statistics.
